Published July 21, 2023

Global Acute Respiratory Distress Syndrome Treatment Market is valued at approximately USD $ billion in 2022 and is anticipated to grow with a healthy growth rate of more than $ over the forecast period 2023-2030. Acute Respiratory Distress Syndrome is a medical condition that can occur in response to various underlying causes, such as pneumonia, sepsis, trauma, or inhalation injury. ARDS is characterized by inflammation and fluid buildup in the lungs, which can lead to severe shortness of breath and respiratory failure.

The Acute Respiratory Distress Syndrome Treatment market is expanding because of factors such as increasing cases of Preterm birth and growing prevalence of respiratory diseases. Treatment of ARDS typically involves supportive care, such as mechanical ventilation to help with breathing, supplemental oxygen, and medications to manage symptoms and prevent complications. Its prevalence has progressively increased during the last few decades.

Request To Download Sample of This Strategic Report:-

According to the World Health Organization, every year, an estimated 15 million babies are born preterm. Furthermore, across countries, the rate of preterm birth ranges from 5% to 18% of babies born. Moreover, more than 90% of extremely preterm babies born in low-income countries die within the first few days of life, yet less than 10% of extremely preterm babies die in high-income settings. Another important component driving space is increased prevalence of respiratory diseases.

According to World Health Organization, Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths. In addition, Chronic obstructive pulmonary disease is the third leading cause of death worldwide, causing 3.23 million deaths Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries in 2019. Also, increasing demand for diagnosis and rising technological advancement in medical testing devices would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Acute Respiratory Distress Syndrome Treatment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Acute Respiratory Distress Syndrome Treatment Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to technological advancements and the availability of numerous cutting-edge pharmacological molecules to improve the therapeutic process. According to Statista, the prevalence of chronic obstructive pulmonary disease in the United States is expected to increase to around 11.6% among adults by the year 2050. Asia Pacific is expected to grow significantly during the forecast period, owing to an increase in biotechnology research and center activity in the market space.

Major market players included in this report are:
F. Hoffmann-La Roche Ltd
Bayer AG
Sun Pharmaceutical Industries Ltd
Novartis AG
Dragerwerk AG & Co. KGaA
Fisher & Paykel Healthcare Limited
LivaNova PLC
Besmed Health Business Corp
Armstrong Medical
Pfizer Inc.

Download Free Sample of This Strategic Report:-

Recent Developments in the Market:
In April 2022, Novartis Pharma introduced Egypt’s first fixed dose combination triple therapy in one device for asthma, with the purpose of enhancing patients’ management as well as their quality of life.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class
Steroids and Antibiotics

By Route of Administration

By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America

To Get More Business Strategies For Request Sample Report:-

Asia Pacific
South Korea
Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Questions the Report Discusses

  • What essential elements emerged from both primary and secondary research?
  • What will the market’s future potential be?
  • Who examines the market report’s complete outcome?
  • What obstacles and problems face the growth of an industry?
  • What does supply chain analysis for products and market size, share mean?
  • Which of the possible manufacturers is still operating in the market?
  • What are the advantages, benefits, and applications of the product’s features?
  • What are the main trends and influencing factors?

Request Full Report-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.

Get in Touch with Us:
Report Ocean:
Email:[email protected]
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1888 212 3539 (US – TOLL FREE)

Source link